NO

Norway

5837 clinical trials

Find Trials

Clinical Trials (5837)

Showing 20 of 5,837 trialsScroll for more
NCT05317416Phase 32 sites

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

Active Not Recruiting
NCT06290141Phase 31 site

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Recruiting
NCT07284849Phase 33 sites

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Recruiting
NCT05166889Phase 37 sites

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

Completed
NCT07100080Phase 23 sites

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Recruiting
NCT06152575Phase 34 sites

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Recruiting
NCT07106762Phase 23 sites

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Recruiting
NCT07107529Phase 22 sites

Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.

Recruiting
NCT07361510Phase 32 sites

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Recruiting
NCT07532317Not Applicable1 site

A Prospective, Multinational, Multicentre, Open-label, Randomized Trial to Evaluatesafety and Effectiveness of Meril's Myval Transcatheter Heart Valve (THV) Series Compared toGuideline-Directed Medical Therapy (GDMT) in Participants With Moderate Aortic Stenosis.

Not Yet Recruiting
NCT07497087Phase 35 sites

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

Not Yet Recruiting
NCT05030428Phase 38 sites

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

Active Not Recruiting
NCT04206228Phase 21 site

Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic Stenosis

Completed
NCT06238622Phase 33 sites

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

Recruiting
NCT03661320Phase 33 sites

A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer

Active Not Recruiting
NCT06963827Phase 36 sites

A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition

Recruiting
NCT07355296Phase 24 sites

PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease

Recruiting
NCT07530731Not Applicable1 site

Platforms Comparison Study - NIXOS-COMPARISON

Not Yet Recruiting
NCT04751487Phase 31 site

Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT07220083Phase 34 sites

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

Recruiting